Overview
Nevro is a publicly traded medical device company specializing in spinal cord stimulation therapy for chronic pain, best known for its HF10 high-frequency SCS platform that operates at 10 kHz to reduce paresthesia. Their devices are FDA-approved for treating intractable back and leg pain.
More in Neuromodulation
Latest industry news
FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
2026-09-23 · Policy
Vagus Nerve Stimulation Enters the Sports Performance Arena With New Anxiety Support Device
2026-09-22 · Product
Aurenar Raises $5.7M to Accelerate Stroke Neuromodulation Device Development
2026-09-21 · Funding
UCANACT Raises €800,000 to Advance Brain-Computer Communication Technology
2026-09-20 · Funding
Company details
Category
⚡ Neuromodulation
Location
Redwood City, USA
Funding
Public · NYSE: NVRO
Website
www.nevro.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →